Trials / Completed
CompletedNCT04069546
The Efficacy of Remote Ischemic Conditioning on Stroke-induced Immunodeficiency
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Capital Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
to detect the effects of RIC on stroke-induced immunodeficiency and inflammation response in acute ischemic stroke patients
Detailed description
Remote ischemic conditioning, consisting of several brief cycles of intermittent ischemia-reperfusion of the arm or leg, may potentially confer systemic protection against prolonged ischemia in a distant organ. Numerous reports have confirmed its strongest endogenous neuroprotection against brain injury after stroke, of which the immune mechanisms are majorly involved in RIC. At the same time, the inflammation response plays a great role in stroke development, which may expand the infarct area. Stroke-induced immunodeficiency can potentiate stroke-associated pneumonia, which is an important cause of death after strokes. In this study, the investigators will assess the effect of RIC on stroke-induced immunodeficiency and inflammation response in AIS patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | remote ischemic conditioning | RIC is a physical strategy performed by an electric device with cuffs placed on the unilateral arm and inflated to 180 mmHg for 5-min followed by deflation for 5-min, the procedures are performed repeatedly for 5 times. |
Timeline
- Start date
- 2019-09-07
- Primary completion
- 2020-02-01
- Completion
- 2020-02-01
- First posted
- 2019-08-28
- Last updated
- 2020-12-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04069546. Inclusion in this directory is not an endorsement.